4264-2256 Screening compound: 1-benzyl-2'-(2-furyl)-1',10b'-dihydrospiro[piperidine-4,5'-pyrazolo[1,5-c][1,3]benzoxazine]

4264-2256 Screening compound: 1-benzyl-2'-(2-furyl)-1',10b'-dihydrospiro[piperidine-4,5'-pyrazolo[1,5-c][1,3]benzoxazine]
4264-2256 Screening compound: 1-benzyl-2'-(2-furyl)-1',10b'-dihydrospiro[piperidine-4,5'-pyrazolo[1,5-c][1,3]benzoxazine] alternative view

Chemical Structure Depiction of ChemDiv screening compound 4264-2256
1-benzyl-2'-(2-furyl)-1',10b'-dihydrospiro[piperidine-4,5'-pyrazolo[1,5-c][1,3]benzoxazine]

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

4264-2256

Molecular Formula

C25H25N3O2 (C25 H25 N3 O2)

Compound Name

1-benzyl-2'-(2-furyl)-1',10b'-dihydrospiro[piperidine-4,5'-pyrazolo[1,5-c][1,3]benzoxazine]

IUPAC name

1-benzyl-4'-(furan-2-yl)-8'-oxa-5'6'-diazaspiro[piperidine-47'-tricyclo[7.4.0.0^{26}]tridecane]-1'(9')4'10'12'-tetraene

SMILES

C(c1ccccc1)N(CC1)CCC1(N(C1C2)N=C2c2ccco2)Oc2c1cccc2

InChI

InChI=1S/C25H25N3O2/c1-2-7-19(8-3-1)18-27-14-12-25(13-15-27)28-22(20-9-4-5-10-23(20)30-25)17-21(26-28)24-11-6-16-29-24/h1-11,16,22H,12-15,17-18H2/t22-/m1/s1

InChI Key

OJRRKHCYTNMAJL-JOCHJYFZSA-N

MDL Number (MFCD)

MFCD02654144

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

399.49

Hydrogen Bond Acceptors Count

4.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

3.00

Number of Nitrogen and Oxygen Atoms

5

Partition Coefficient, logP

4.672

Distribution Coefficient, logD

4.024

Water Solubility, LogSw

-4.76

Polar Surface Area

32.971

Acid Dissociation Constant (pKa)

17.70

Base Dissociation Constant (pKb)

7.94

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

32.00

4264-2256 in Drug Discovery

Included in Screening Libraries

Anti-infective Library (19449 compounds)

GPCR Targeted Library (31838 compounds)

Protein-Protein Interaction Library (218420 compounds)

Spiro Library (21655 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

MCE-18 Trends in Medicinal Chemistry (51288 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Infections
  • Immune system
  • animal
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands
  • PPI modulators
  • PPI modulators
Structure:
  • Cyclic compounds
  • Cyclic compounds

References: we are preparing a list of scientific research reports with 4264-2256 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound 4264-2256?
Check Price and Availability of 4264-2256, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of 4264-2256 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for 4264-2256
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for 4264-2256
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of 4264-2256 available by request